{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T02:42:34Z","timestamp":1769827354583,"version":"3.49.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009169","name":"Assiut University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009169","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Familial hypercholesterolemia (FH) is a world public health problem that enhances the risk of premature coronary artery disease (CAD) with a high incidence of acute coronary syndrome. This study aimed to evaluate the clinical and angiographic characteristics of the patients with and without FH who had ST-elevation myocardial infarction (STEMI). It included 690 patients who presented with the first attack of STEMI and underwent primary percutaneous coronary interventions (PPCI). The patients were analyzed to diagnose FH according to the Dutch Lipid Clinic Network (DLCN) criteria. All angiograms were analyzed for the number of diseased vessels, Syntax score, thrombus burden grade, and final Thrombolysis in Myocardial Infarction (TIMI) flow grade. The majority of patients were male (72.6%) with a mean age of 54\u2009\u00b1\u200912 years. Based on DLCN criteria, they were classified into unlikely\/possible FH (86.1%) and probable\/definite FH (13.9%) groups. Probable\/definite FH patients were significantly younger, and higher incidence of males\u2009&lt;\u200955 years compared with unlikely\/possible FH patients (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001 for each). Moreover, probable\/definite FH patients had a higher frequency of three-vessel disease (<jats:italic>p<\/jats:italic>\u2009=\u20090.007) and Syntax score (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) with a moderate positive correlation with the DLCN score (<jats:italic>r<\/jats:italic>\u2009=\u20090.592, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Furthermore, probable\/definite FH patients showed a higher thrombus burden and final TIMI slow\/no-reflow when compared to the unlikely\/possible FH patients (<jats:italic>p<\/jats:italic>\u2009=\u20090.006 and <jats:italic>p<\/jats:italic>\u2009=\u20090.027, respectively). Patients with probable\/definite FH and LDL-C level were independent predictors of high thrombus burden besides males\u2009&lt;\u200955 years, and the number of diseased vessels. In conclusion, STEMI patients with FH were younger males and associated with severe CAD with frequent multivessel CAD, high anatomical complexity of CAD, and frequent high thrombus burden. Furthermore, FH was one of the predictors of high thrombus burden.<\/jats:p>","DOI":"10.1038\/s41598-024-77656-4","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T12:01:43Z","timestamp":1730980903000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical and angiographic characteristics of patients with familial hypercholesterolemia presenting with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention"],"prefix":"10.1038","volume":"14","author":[{"given":"Khaled M.","family":"Elmaghraby","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Abdel-Galeel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amira Harby","family":"Osman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hosam","family":"Hasan-Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Aboel-Kassem F.","family":"Abdelmegid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,7]]},"reference":[{"key":"77656_CR1","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1016\/j.jacc.2020.03.058","volume":"75","author":"JJP Kastelein","year":"2020","unstructured":"Kastelein, J. J. P., Reeskamp, L. F. & Hovingh, G. K. Familial hypercholesterolemia: the most common monogenic disorder in humans. J. Am. Coll. Cardiol. 75, 2567\u20132569. https:\/\/doi.org\/10.1016\/j.jacc.2020.03.058 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"77656_CR2","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1055\/s-2004-822987","volume":"4","author":"JC Defesche","year":"2004","unstructured":"Defesche, J. C., Lansberg, P. J., Umans-Eckenhausen, M. A. & Kastelein, J. J. Advanced method for the identification of patients with inherited hypercholesterolemia. Semin Vasc Med. 4, 59\u201365. https:\/\/doi.org\/10.1055\/s-2004-822987 (2004).","journal-title":"Semin Vasc Med."},{"key":"77656_CR3","doi-asserted-by":"publisher","first-page":"3956","DOI":"10.1210\/jc.2012-1563","volume":"97","author":"M Benn","year":"2012","unstructured":"Benn, M., Watts, G. F., Tybjaerg-Hansen, A. & Nordestgaard, B. G. Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication. J. Clin. Endocrinol. Metab. 97, 3956\u20133964. https:\/\/doi.org\/10.1210\/jc.2012-1563 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"77656_CR4","doi-asserted-by":"publisher","unstructured":"Mainieri, F., Tagi, V. M. & Chiarelli, F. Recent Advances on Familial Hypercholesterolemia in Children and Adolescents. Biomedicines 10, doi: (2022). https:\/\/doi.org\/10.3390\/biomedicines10051043","DOI":"10.3390\/biomedicines10051043"},{"issue":"a","key":"77656_CR5","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","volume":"34","author":"BG Nordestgaard","year":"2013","unstructured":"Nordestgaard, B. G. et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur. Heart J. 34(a), 3478\u20133490. https:\/\/doi.org\/10.1093\/eurheartj\/eht273 (2013).","journal-title":"Eur. Heart J."},{"key":"77656_CR6","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1016\/j.jacc.2019.02.059","volume":"73","author":"A Singh","year":"2019","unstructured":"Singh, A. et al. Familial hypercholesterolemia among young adults with myocardial infarction. J. Am. Coll. Cardiol. 73, 2439\u20132450. https:\/\/doi.org\/10.1016\/j.jacc.2019.02.059 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"77656_CR7","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.jacl.2021.04.005","volume":"15","author":"B Kheiri","year":"2021","unstructured":"Kheiri, B. et al. Familial hypercholesterolemia related admission for acute coronary syndrome in the United States: incidence, predictors, and outcomes. J. Clin. Lipidol. 15, 460\u2013465. https:\/\/doi.org\/10.1016\/j.jacl.2021.04.005 (2021).","journal-title":"J. Clin. Lipidol."},{"key":"77656_CR8","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1590\/1806-9282.67.02.20200548","volume":"67","author":"E Acikgoz","year":"2021","unstructured":"Acikgoz, E., Acikgoz, S. K., Yaman, B. & Kurtul, A. Lower LDL-cholesterol levels associated with increased inflammatory burden in patients with acute ST-segment elevation myocardial infarction. Rev. Assoc. Med. Bras. (1992). 67, 224\u2013229. https:\/\/doi.org\/10.1590\/1806-9282.67.02.20200548 (2021).","journal-title":"Rev. Assoc. Med. Bras. (1992)"},{"key":"77656_CR9","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1161\/ATVBAHA.116.308456","volume":"37","author":"JJ Li","year":"2017","unstructured":"Li, J. J. et al. Familial hypercholesterolemia phenotype in Chinese patients undergoing coronary angiography. Arterioscler. Thromb. Vasc Biol. 37, 570\u2013579. https:\/\/doi.org\/10.1161\/ATVBAHA.116.308456 (2017).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"key":"77656_CR10","doi-asserted-by":"publisher","first-page":"8861","DOI":"10.1038\/s41598-018-27248-w","volume":"8","author":"S Li","year":"2018","unstructured":"Li, S. et al. Familial hypercholesterolemia in very young myocardial infarction. Sci. Rep. 8, 8861. https:\/\/doi.org\/10.1038\/s41598-018-27248-w (2018).","journal-title":"Sci. Rep."},{"key":"77656_CR11","doi-asserted-by":"publisher","unstructured":"Wang, X. et al. Comparison of long-term outcomes of young patients after a coronary event associated with familial hypercholesterolemia. Lipids Health Dis. 18https:\/\/doi.org\/10.1186\/s12944-019-1074-8 (2019).","DOI":"10.1186\/s12944-019-1074-8"},{"key":"77656_CR12","doi-asserted-by":"publisher","unstructured":"Yao, H. et al. Coronary lesion complexity in patients with heterozygous familial hypercholesterolemia hospitalized for acute myocardial infarction: data from the RICO survey. Lipids Health Dis. 20https:\/\/doi.org\/10.1186\/s12944-021-01467-z (2021).","DOI":"10.1186\/s12944-021-01467-z"},{"key":"77656_CR13","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","volume":"72","author":"K Thygesen","year":"2018","unstructured":"Thygesen, K. et al. Fourth Universal Definition of Myocardial Infarction (2018). J. Am. Coll. Cardiol. 72, 2231\u20132264. https:\/\/doi.org\/10.1016\/j.jacc.2018.08.1038 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"77656_CR14","unstructured":"Wingo, P. A. et al. (World Health Organization, Geneva, (1994)."},{"key":"77656_CR15","first-page":"219","volume":"1","author":"G Sianos","year":"2005","unstructured":"Sianos, G. et al. The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 1, 219\u2013227 (2005).","journal-title":"EuroIntervention"},{"key":"77656_CR16","first-page":"6B","volume":"22","author":"G Sianos","year":"2010","unstructured":"Sianos, G., Papafaklis, M. I. & Serruys, P. W. Angiographic thrombus burden classification in patients with ST-segment elevation myocardial infarction treated with percutaneous coronary intervention. J. Invasive Cardiol. 22, 6B\u201314B (2010).","journal-title":"J. Invasive Cardiol."},{"key":"77656_CR17","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1056\/NEJM198504043121437","volume":"312","author":"TS Group","year":"1985","unstructured":"Group, T. S. The Thrombolysis in myocardial infarction (TIMI) trial. Phase I findings. N Engl. J. Med. 312, 932\u2013936. https:\/\/doi.org\/10.1056\/NEJM198504043121437 (1985).","journal-title":"N Engl. J. Med."},{"key":"77656_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.echo.2014.09.009","volume":"28","author":"TR Porter","year":"2015","unstructured":"Porter, T. R. et al. Guidelines for the use of echocardiography as a monitor for therapeutic intervention in adults: a report from the American Society of Echocardiography. J. Am. Soc. Echocardiogr. 28, 40\u201356. https:\/\/doi.org\/10.1016\/j.echo.2014.09.009 (2015).","journal-title":"J. Am. Soc. Echocardiogr"},{"key":"77656_CR19","first-page":"669","volume":"14","author":"RN Pejic","year":"2014","unstructured":"Pejic, R. N. Familial hypercholesterolemia. Ochsner J. 14, 669\u2013672 (2014).","journal-title":"Ochsner J."},{"key":"77656_CR20","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.cjca.2019.06.017","volume":"35","author":"AI Kramer","year":"2019","unstructured":"Kramer, A. I., Trinder, M. & Brunham, L. R. Estimating the prevalence of familial hypercholesterolemia in Acute Coronary Syndrome: a systematic review and Meta-analysis. Can. J. Cardiol. 35, 1322\u20131331. https:\/\/doi.org\/10.1016\/j.cjca.2019.06.017 (2019).","journal-title":"Can. J. Cardiol."},{"key":"77656_CR21","doi-asserted-by":"publisher","unstructured":"Danchin, N. et al. Long-term outcomes after acute myocardial infarction in patients with familial hypercholesterolemia: The French registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction program. J Clin Lipidol 14, 352\u2013360 e356, doi: (2020). https:\/\/doi.org\/10.1016\/j.jacl.2020.03.008","DOI":"10.1016\/j.jacl.2020.03.008"},{"key":"77656_CR22","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.jacl.2019.06.005","volume":"13","author":"M Farnier","year":"2019","unstructured":"Farnier, M. et al. Prevalence, risk factor burden, and severity of coronary artery disease in patients with heterozygous familial hypercholesterolemia hospitalized for an acute myocardial infarction: data from the French RICO survey. J. Clin. Lipidol. 13, 601\u2013607. https:\/\/doi.org\/10.1016\/j.jacl.2019.06.005 (2019).","journal-title":"J. Clin. Lipidol."},{"key":"77656_CR23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jacl.2018.09.012","volume":"13","author":"M Tscharre","year":"2019","unstructured":"Tscharre, M. et al. Prognostic impact of familial hypercholesterolemia on long-term outcomes in patients undergoing percutaneous coronary intervention. J. Clin. Lipidol. 13, 115\u2013122. https:\/\/doi.org\/10.1016\/j.jacl.2018.09.012 (2019).","journal-title":"J. Clin. Lipidol."},{"key":"77656_CR24","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1161\/CIRCGENETICS.116.001381","volume":"9","author":"EM deGoma","year":"2016","unstructured":"deGoma, E. M. et al. Treatment gaps in adults with heterozygous familial hypercholesterolemia in the United States: Data from the CASCADE-FH Registry. Circ. Cardiovasc. Genet. 9, 240\u2013249. https:\/\/doi.org\/10.1161\/CIRCGENETICS.116.001381 (2016).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"77656_CR25","doi-asserted-by":"publisher","first-page":"e019286","DOI":"10.1161\/JAHA.120.019286","volume":"10","author":"N Ryzhaya","year":"2021","unstructured":"Ryzhaya, N. et al. Sex differences in the presentation, treatment, and outcome of patients with familial hypercholesterolemia. J. Am. Heart Assoc. 10, e019286. https:\/\/doi.org\/10.1161\/JAHA.120.019286 (2021).","journal-title":"J. Am. Heart Assoc."},{"key":"77656_CR26","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jacl.2022.11.009","volume":"17","author":"A Agarwala","year":"2023","unstructured":"Agarwala, A. et al. Sex-related differences in premature cardiovascular disease in familial hypercholesterolemia. J. Clin. Lipidol. 17, 150\u2013156. https:\/\/doi.org\/10.1016\/j.jacl.2022.11.009 (2023).","journal-title":"J. Clin. Lipidol."},{"issue":"C","key":"77656_CR27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.2471\/BLT.13.121954","volume":"92","author":"N Ikeda","year":"2014","unstructured":"Ikeda, N. et al. Control of hypertension with medication: a comparative analysis of national surveys in 20 countries. Bull. World Health Organ. 92(C), 10\u201319. https:\/\/doi.org\/10.2471\/BLT.13.121954 (2014).","journal-title":"Bull. World Health Organ."},{"key":"77656_CR28","unstructured":"Ministry of Health and Population (Egypt), El-Zanaty, Associates (Egypt) & ICF International. Egypt Health Issues Survey 2015. (Ministry of Health and Population (Egypt) and ICF International, Cairo, Egypt. (2015)."},{"key":"77656_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.atherosclerosis.2019.06.899","volume":"288","author":"K Dyrbus","year":"2019","unstructured":"Dyrbus, K. et al. The prevalence and management of familial hypercholesterolemia in patients with acute coronary syndrome in the Polish tertiary centre: results from the TERCET registry with 19,781 individuals. Atherosclerosis. 288, 33\u201341. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.06.899 (2019).","journal-title":"Atherosclerosis"},{"key":"77656_CR30","doi-asserted-by":"publisher","unstructured":"Elbadawi, A. et al. Outcomes of Acute Myocardial Infarction in Patients with Familial Hypercholesteremia. Am J Med 134, 992\u20131001 e1004, doi: (2021). https:\/\/doi.org\/10.1016\/j.amjmed.2021.03.013","DOI":"10.1016\/j.amjmed.2021.03.013"},{"key":"77656_CR31","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/s0002-9149(83)80105-2","volume":"51","author":"GG Gensini","year":"1983","unstructured":"Gensini, G. G. A more meaningful scoring system for determining the severity of coronary heart disease. Am. J. Cardiol. 51, 606. https:\/\/doi.org\/10.1016\/s0002-9149(83)80105-2 (1983).","journal-title":"Am. J. Cardiol."},{"key":"77656_CR32","doi-asserted-by":"publisher","first-page":"e0186815","DOI":"10.1371\/journal.pone.0186815","volume":"12","author":"R Auckle","year":"2017","unstructured":"Auckle, R. et al. Familial hypercholesterolemia in Chinese patients with premature ST-segment-elevation myocardial infarction: prevalence, lipid management and 1-year follow-up. PLoS One. 12, e0186815. https:\/\/doi.org\/10.1371\/journal.pone.0186815 (2017).","journal-title":"PLoS One"},{"key":"77656_CR33","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s43044-022-00320-7","volume":"74","author":"P Kumar","year":"2022","unstructured":"Kumar, P., Prasad, S. R., Anand, A., Kumar, R. & Ghosh, S. Prevalence of familial hypercholesterolemia in patients with confirmed premature coronary artery disease in Ranchi, Jharkhand. Egypt. Heart J. 74, 83. https:\/\/doi.org\/10.1186\/s43044-022-00320-7 (2022).","journal-title":"Egypt. Heart J."},{"key":"77656_CR34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ahj.2016.08.001","volume":"181","author":"SA Rerup","year":"2016","unstructured":"Rerup, S. A. et al. The prevalence and prognostic importance of possible familial hypercholesterolemia in patients with myocardial infarction. Am. Heart J. 181, 35\u201342. https:\/\/doi.org\/10.1016\/j.ahj.2016.08.001 (2016).","journal-title":"Am. Heart J."},{"key":"77656_CR35","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1253\/jcj.65.247","volume":"65","author":"T Yasuda","year":"2001","unstructured":"Yasuda, T. et al. Coronary lesion morphology and prognosis in young males with myocardial infarction with or without familial hypercholesterolemia. Jpn Circ. J. 65, 247\u2013250. https:\/\/doi.org\/10.1253\/jcj.65.247 (2001).","journal-title":"Jpn Circ. J."},{"key":"77656_CR36","doi-asserted-by":"publisher","first-page":"4112","DOI":"10.1093\/eurheartj\/ehy562","volume":"39","author":"GW Stone","year":"2018","unstructured":"Stone, G. W. et al. Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial. Eur. Heart J. 39, 4112\u20134121. https:\/\/doi.org\/10.1093\/eurheartj\/ehy562 (2018).","journal-title":"Eur. Heart J."},{"key":"77656_CR37","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/j.jacc.2017.09.011","volume":"70","author":"RW Yeh","year":"2017","unstructured":"Yeh, R. W. et al. Lesion complexity and outcomes of extended dual antiplatelet therapy after percutaneous coronary intervention. J. Am. Coll. Cardiol. 70, 2213\u20132223. https:\/\/doi.org\/10.1016\/j.jacc.2017.09.011 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"Suppl 1","key":"77656_CR38","first-page":"3","volume":"33","author":"T Horie","year":"1999","unstructured":"Horie, T. [Histopathological findings of coronary arteries in cases with acute coronary syndromes]. J. Cardiol. 33(Suppl 1), 3\u20138 (1999).","journal-title":"J. Cardiol."},{"key":"77656_CR39","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1161\/01.CIR.0000065220.70220.F7","volume":"107","author":"CH Chen","year":"2003","unstructured":"Chen, C. H. et al. Low-density lipoprotein in hypercholesterolemic human plasma induces vascular endothelial cell apoptosis by inhibiting fibroblast growth factor 2 transcription. Circulation.  107, 2102\u20132108. https:\/\/doi.org\/10.1161\/01.CIR.0000065220.70220.F7 (2003).","journal-title":"Circulation"},{"key":"77656_CR40","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1194\/jlr.M500481-JLR200","volume":"48","author":"HH Chen","year":"2007","unstructured":"Chen, H. H. et al. Electronegative LDLs from familial hypercholesterolemic patients are physicochemically heterogeneous but uniformly proapoptotic. J. Lipid Res. 48, 177\u2013184. https:\/\/doi.org\/10.1194\/jlr.M500481-JLR200 (2007).","journal-title":"J. Lipid Res."},{"key":"77656_CR41","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.1182\/blood-2013-05-504639","volume":"122","author":"HC Chan","year":"2013","unstructured":"Chan, H. C. et al. Highly electronegative LDL from patients with ST-elevation myocardial infarction triggers platelet activation and aggregation. Blood. 122, 3632\u20133641. https:\/\/doi.org\/10.1182\/blood-2013-05-504639 (2013).","journal-title":"Blood"},{"key":"77656_CR42","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1194\/jlr.R067314","volume":"57","author":"K Schmidt","year":"2016","unstructured":"Schmidt, K., Noureen, A., Kronenberg, F. & Utermann, G. Structure, function, and genetics of lipoprotein (a). J. Lipid Res. 57, 1339\u20131359. https:\/\/doi.org\/10.1194\/jlr.R067314 (2016).","journal-title":"J. Lipid Res."},{"key":"77656_CR43","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1016\/j.jacc.2014.01.063","volume":"63","author":"R Alonso","year":"2014","unstructured":"Alonso, R. et al. Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation. J. Am. Coll. Cardiol. 63, 1982\u20131989. https:\/\/doi.org\/10.1016\/j.jacc.2014.01.063 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"77656_CR44","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1194\/jlr.R060582","volume":"57","author":"MB Boffa","year":"2016","unstructured":"Boffa, M. B. & Koschinsky, M. L. Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease? J. Lipid Res. 57, 745\u2013757. https:\/\/doi.org\/10.1194\/jlr.R060582 (2016).","journal-title":"J. Lipid Res."},{"key":"77656_CR45","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1159\/000529600","volume":"148","author":"DM Sankhesara","year":"2023","unstructured":"Sankhesara, D. M. et al. Lipoprotein(a) is Associated with Thrombus burden in culprit arteries of younger patients with ST-Segment Elevation myocardial infarction. Cardiology.  148, 98\u2013102. https:\/\/doi.org\/10.1159\/000529600 (2023).","journal-title":"Cardiology"},{"key":"77656_CR46","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1056\/NEJM197402212900805","volume":"290","author":"AC Carvalho","year":"1974","unstructured":"Carvalho, A. C., Colman, R. W. & Lees, R. S. Platelet function in hyperlipoproteinemia. N Engl. J. Med. 290, 434\u2013438. https:\/\/doi.org\/10.1056\/NEJM197402212900805 (1974).","journal-title":"N Engl. J. Med."},{"key":"77656_CR47","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1177\/0003319715579781","volume":"67","author":"A Icli","year":"2016","unstructured":"Icli, A. et al. Increased Mean platelet volume in familial hypercholesterolemia. Angiology. 67, 146\u2013150. https:\/\/doi.org\/10.1177\/0003319715579781 (2016).","journal-title":"Angiology"},{"key":"77656_CR48","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1136\/hrt.53.3.265","volume":"53","author":"DD Sugrue","year":"1985","unstructured":"Sugrue, D. D. et al. Coronary artery disease and haemostatic variables in heterozygous familial hypercholesterolaemia. Br. Heart J. 53, 265\u2013268. https:\/\/doi.org\/10.1136\/hrt.53.3.265 (1985).","journal-title":"Br. Heart J."},{"key":"77656_CR49","doi-asserted-by":"publisher","first-page":"5688","DOI":"10.1182\/blood-2010-03-277079","volume":"116","author":"N Martinelli","year":"2010","unstructured":"Martinelli, N. et al. Polymorphisms at LDLR locus may be associated with coronary artery disease through modulation of coagulation factor VIII activity and independently from lipid profile. Blood.  116, 5688\u20135697. https:\/\/doi.org\/10.1182\/blood-2010-03-277079 (2010).","journal-title":"Blood"},{"key":"77656_CR50","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/joim.12812","volume":"284","author":"P Benedek","year":"2018","unstructured":"Benedek, P. et al. Genetic testing for familial hypercholesterolemia among survivors of acute coronary syndrome. J. Intern. Med. 284, 674\u2013684. https:\/\/doi.org\/10.1111\/joim.12812 (2018).","journal-title":"J. Intern. Med."},{"key":"77656_CR51","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ejim.2015.01.014","volume":"26","author":"DS Wald","year":"2015","unstructured":"Wald, D. S., Bangash, F. A. & Bestwick, J. P. Prevalence of DNA-confirmed familial hypercholesterolaemia in young patients with myocardial infarction. Eur. J. Intern. Med. 26, 127\u2013130. https:\/\/doi.org\/10.1016\/j.ejim.2015.01.014 (2015).","journal-title":"Eur. J. Intern. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77656-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77656-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77656-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T12:05:37Z","timestamp":1730981137000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77656-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,7]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["77656"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-77656-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,7]]},"assertion":[{"value":"7 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the ethical and medical research committee, Faculty of Medicine, Assiut University (approval number: 17100752) and complies with the Declaration of Helsinki. Informed written consent was obtained from all participants after an explanation of all steps of the study. It was explained to all participants that the collected data was confidential and for scientific research only.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"27098"}}